Veterinary Vaccines Market is Expected to Reach $13.51 bn by 2027
Generally, vaccines are effective in preventing infectious diseases. Veterinary vaccines especially reduce the burden of the disease in animals and also helps in preventing several zoonotic diseases also. There are four types of veterinary vaccines available depending on preparation type, they are live-attenuated or inactivated, recombinant vaccines, RNA/DNA based & vectored-based vaccines and toxoid vaccines. Veterinary vaccines are generally used for transboundary animal diseases such as Rift valley fever, Foot and Mouth Disease, Bluetongue, African horse sickness, Contagious bovine pleuropneumonia, Hemorrhagic septicemia, Brucellosis, Cattle vaccines, and small ruminant vaccines.
Globally, the rise of livestock population affected by Foot & Mouth Disease is about 77% while around 500,000 livestock succumbs to Brucellosis. In recent times, there is a surge in the livestock population and companion animals, especially cattle, cats and dogs. It is estimated that in 2018 alone the population of livestock was more than 990 million cattle, cats being 373 million and dogs being 471 million dogs and it is expected to rise more in the forthcoming years. Thus, the demand for animal vaccines is high and is expected to contribute principally to market growth.
The veterinary vaccines market can be classified into two major segments, livestock vaccines (consists of farm animals like cattle, pigs, sheep, poultry, aquaculture & bees) and companion animals (consists of dogs, cats & horses). Recombinant vaccines are the fastest-growing segments in the forecast period
The major market drivers for the veterinary vaccines market include an increase in livestock population and adoption of pet animals, growing incidence of animal diseases and awareness of animal health and an increase in pet healthcare expenditure. While high storage cost and maintenance of vaccines are key restraints for veterinary vaccines market growth.
An increase in demand and usage of animal products and dairy products are also expected to boost the veterinary vaccines market. Focusing on animal health & welfare and promotional activities explaining the advantages of vaccination will aid the animal vaccine market growth positively.
Public & private partnerships for the manufacturing of vaccines, vaccine technology development, distribution & accessibility might impact the market growth positively during the forecast period. Development of Novel biotechnological vaccines and technological advancements in the development of newer vaccines for various infectious diseases are major challenges for the veterinary vaccines market.
Request for Sample Pages @ https://www.optimainsights.org/sample-request/146-veterinary-vaccine-market
Major companies for Veterinary Vaccines market include Merck, Bayer Healthcare, Sanofi-Aventis, Virbac, Novartis Animal Health, Boehringer Ingelheim, Wyeth and many more....
Boehringer Ingelheim is investing more than US $189.82 million into developing one of the largest biotechnology production sites for veterinary vaccines in Europe
Merck Animal Health Completes Acquisition of Vaki to Further Broaden Its Leadership Position in Aquaculture to Advance Fish Health and Welfare
Based on Animal Type (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn):
Based on Geographic Region (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn)
Provides a detailed Analysis of the Market Structure along with forecast of the various segments and sub-segments.
Provides a Comparative Analysis of Key Marketed and Pipeline Products.
Provides Key Information on Players involved.
Provides a Complete Overview of Market Segments and the Regional Outlook.
Provides In-depth Coverage of Key News, including Major Mergers, Acquisitions and Product Development updates such as clinical trial progression updates and regulatory updates.
The Report Provides Key Insights on
History of the Veterinary Vaccines Market, 2015 to 2018
Forecast of the Veterinary Vaccines Market Growth till the year 2027
The key market drivers, restraints, challenges, future opportunities and the market dynamics driving the Veterinary Vaccines Market
Analysis of potential growth segments which will drive the market
Landscape analysis of the major companies, and new market entrants and companies which possess disruptive technologies which can change the trend of the entire market
Key market approaches adopted by the organizations and in-depth intelligence of potential strategies which could alter the market dynamics
Request for TOC @ https://www.optimainsights.org/request-toc/146-veterinary-vaccine-market
Mr Chucks G
+91 966 6620 365 (Asia) | +1 424 2554 365 (US)
Optima Insights is an innovative research and insights-driven enterprise committed to offering actionable intelligence to the global life science and healthcare market. We believe that meaningful insights and improved strategic content hold the key to improved ROI for our clients. We strike an innovative engagement model with our clients to Co-Create Intelligence that would address very specific issues facing them within their functional areas. We continuously support clients through the entire journey map to enable them to make better business decisions towards attaining market leadership.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Veterinary Vaccines Market is Expected to Reach $13.51 bn by 2027 here
News-ID: 1927237 • Views: 322
More Releases from Optima insights Pvt Ltd
Endometriosis Treatment Market is Expected to Reach $3.43 bn by 2027
The Endometriosis Treatment Market was valued at US $2.64 billion in the year 2019 and is estimated to reach US $3.43 billion by 2027, at a CAGR of 3.36%. The growth of tissue outside the uterus similar to lining of uterus (endometrium) refers to Endometriosis. Areas of endometrial tissue growth often occur in ovaries, fallopian tubes, peritoneum and outer surfaces of bladder, uterus, intestines, and rectum and rarely spread beyond pelvic
Inflammatory Bowel Disease (IBD) Treatment Market is Expected to Reach $15.5 bn …
The Inflammatory Bowel Disease (IBD) treatment market share was US$ 11.38 Bn in the year 2018. The market is anticipated to grow at a rate of 3.94%, through the forecast period to reach US$ 15.5 Bn by the year 2027. Inflammatory Bowel Disease (IBD) usually denotes disorders characterized by the inflammation in the digestive system. Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome are two different disorders that are often confused
Polycystic Ovarian Syndrome (PCOS) Treatment Market is Expected to Reach $5.59 b …
The Polycystic Ovarian Syndrome (PCOS) Treatment Market was valued at US $3.74 billion in the year 2019 and is estimated to reach US $5.59 billion by 2027, at a CAGR of 5.18%. Polycystic Ovarian Syndrome (PCOS), also referred to as Stein-Leventhal syndrome is a hormonal disorder characterized by enlarged ovaries and formation of numerous small cysts (fluid-filled sacs) on the outer edges of the ovaries. Symptoms of PCOS include irregular periods,
Animal Feed Additives Market is Expected to Reach $47.75 bn by 2026
The Animal Feed Additives Market was valued at US$35.82 billion in the year 2018 and is estimated to reach US$47.75 billion by 2026, at a CAGR of 3.66%. Feed additives are substances that enhance the nutritional efficiency of animals. The use of additives in veterinary feed is practiced from the early 1960s, especially, antibiotics are an integral part of veterinary health. Besides, several feed additives including probiotics, amino acids, vitamins and
More Releases for Veterinary
Veterinary Artificial Insemination Market Analysis
The findings reviewed by GME stated that the Global Veterinary Artificial Insemination Market will expand with a CAGR value of 5.9 % from 2021 to 2026. Increasing demand for animal products like dairy and meat is expected to increase the demand for artificial insemination as livestock breeders try to meet the growing demand for animal products. Browse 159 Market Data Tables and 119 Figures spread through 189 Pages and in-depth TOC
Veterinary Clinics Services Market 2020 Strategic Assessments – Pol Veterinary …
Veterinary Clinics Services Market research report provides an actual industry viewpoint, future trends, and dynamics for market growth rate, market size, trading and key players of the industry with a forecast period of 2025. This comprehensive research report is titled Veterinary Clinics Services Market with Industry Analysis and Opportunity Assessment and it comprises a whole market scenario along with the dynamics affecting it. Top leading Companies of Global Veterinary Clinics Services
Veterinary Drugs Market - Segmentation Details
The global veterinary drugs market is reasonably consolidated, with the top ten companies accounting for more than 70% of the overall market in 2015. Leading companies in the global veterinary drugs market include Merck Animal Health, Elanco Animal Health, Zoetis Inc., Bayer Animal Health, and Merial Animal Health. Fierce competition is the norm in the global veterinary drugs market due to the increasing commercial potential of the market and the
Veterinary Grooming Equipment Market
The global veterinary grooming equipment market is segmented into product type such as blades, trimmers & clippers, shampoos & sprays, bathers & dryers, shears, tools and others. Among these segments, shampoos & sprays segment is expected to occupy the top position in global veterinary grooming equipment market. Further, wide product line of veterinary shampoo & sprayers such as herbal shampoo, organic shampoo, anti-flea shampoo and others is expected to
Veterinary Healthcare Market Report 2017
Reports And Markets Publish a New Market Research Report On –"Veterinary Healthcare Market Report 2017" Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/asia-pacific-veterinary-healthcare-market-report-2017-1541125 In this report, the Asia-Pacific Veterinary Healthcare market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with
Global Veterinary Vaccines Market
The Global Veterinary Vaccines Market was valued at US$ 5,688.7 million in 2015 and is projected to expand at a CAGR of 5.9% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Rise in incidence of food-borne zoonotic diseases along with increase in population of livestock is expected to favor growth of the veterinary vaccines market. According to European food safety authority (EFSA),